These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12093933)

  • 1. Managing stimulant medication for attention-deficit/hyperactivity disorder: an update.
    Wender EH
    Pediatr Rev; 2002 Jul; 23(7):234-6. PubMed ID: 12093933
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing stimulant medication for attention-deficit/hyperactivity disorder.
    Wender EH
    Pediatr Rev; 2001 Jun; 22(6):183-90. PubMed ID: 11389305
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014.
    Burcu M; Zito JM; Metcalfe L; Underwood H; Safer DJ
    JAMA Psychiatry; 2016 Sep; 73(9):992-3. PubMed ID: 27331629
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology of adult ADHD with stimulants.
    Spencer TJ
    CNS Spectr; 2007 Apr; 12(4 Suppl 6):8-11. PubMed ID: 17715564
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug treatment of ADHD - tenuous scientific basis.
    Vogt H; Lunde C
    Tidsskr Nor Laegeforen; 2018 Jan; 138(2):. PubMed ID: 29357653
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis.
    Faraone SV; Biederman J; Roe C
    J Clin Psychopharmacol; 2002 Oct; 22(5):468-73. PubMed ID: 12352269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ADHD in patients unresponsive to methylphenidate.
    Hechtman L
    J Psychiatry Neurosci; 2011 May; 36(3):216. PubMed ID: 21496443
    [No Abstract]   [Full Text] [Related]  

  • 10. Current pharmacotherapy of attention deficit hyperactivity disorder.
    Reddy DS
    Drugs Today (Barc); 2013 Oct; 49(10):647-65. PubMed ID: 24191257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication.
    Brossard-Racine M; Shevell M; Snider L; Bélanger SA; Majnemer A
    Res Dev Disabil; 2012; 33(6):2080-7. PubMed ID: 22796639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason.
    Batra AS; Alexander ME; Silka MJ
    Pediatr Cardiol; 2012 Mar; 33(3):394-401. PubMed ID: 22298228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.
    Olfson M; Huang C; Gerhard T; Winterstein AG; Crystal S; Allison PD; Marcus SC
    J Am Acad Child Adolesc Psychiatry; 2012 Feb; 51(2):147-56. PubMed ID: 22265361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder.
    Grcevich S; Rowane WA; Marcellino B; Sullivan-Hurst S
    J Child Adolesc Psychopharmacol; 2001; 11(1):35-41. PubMed ID: 11322743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
    Greenhill LL; Pliszka S; Dulcan MK; Bernet W; Arnold V; Beitchman J; Benson RS; Bukstein O; Kinlan J; McClellan J; Rue D; Shaw JA; Stock S;
    J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2 Suppl):26S-49S. PubMed ID: 11833633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
    Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach.
    DeSantis AD; Webb EM; Noar SM
    J Am Coll Health; 2008; 57(3):315-24. PubMed ID: 18980888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study.
    Faraone SV; Short EJ; Biederman J; Findling RL; Roe C; Manos MJ
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):121-9. PubMed ID: 12135536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.
    Stowe CD; Gardner SF; Gist CC; Schulz EG; Wells TG
    Ann Pharmacother; 2002; 36(7-8):1142-9. PubMed ID: 12086544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
    Castaneda R; Levy R; Hardy M; Trujillo M
    Psychiatr Serv; 2000 Feb; 51(2):169-71. PubMed ID: 10654994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.